1. Market Research
  2. > Healthcare Market Trends
  3. > Bayer HealthCare AG - Product Pipeline Analysis, 2016 Update

Summary
Bayer HealthCare AG (Bayer Healthcare), a division of the Bayer Group, is a healthcare company. It designs, researches, develops, manufactures and sells pharmaceuticals and consumer health products. The company provides prescription pharmaceuticals, such as anticoagulants; treatments for cancer, hemophilia, multiple sclerosis, pulmonary hypertension, eye diseases, infectious diseases, high blood pressure and contraceptives; and over-the-counter (OTC) medications, nutritional supplements, dermatology products, veterinary medicines and animal grooming products, injection systems and contrast agents for diagnostic procedures. Bayer Healthcare markets its products across the world (including Europe, North America, Asia Pacific, Latin America, Africa and Middle East through regional and national distribution companies. Bayer Healthcare is headquartered in Leverkusen, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Bayer HealthCare AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Bayer HealthCare AG - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Bayer HealthCare AG Company Overview 7
Bayer HealthCare AG Company Snapshot 7
Bayer HealthCare AG Pipeline Products and Clinical Trials Overview 8
Bayer HealthCare AG - Pipeline Analysis Overview 10
Business Description 10
Key Facts 10
Bayer HealthCare AG - Major Products and Services 11
Bayer HealthCare AG Pipeline Products by Development Stage 13
Bayer HealthCare AG Pipeline Products Overview 16
AKT1/2 Inhibitor Based Companion Diagnostic Assay 16
AKT1/2 Inhibitor Based Companion Diagnostic Assay Product Overview 16
Analgesic Coated Silica Gel Fiber 17
Analgesic Coated Silica Gel Fiber Product Overview 17
Anetumab Ravtansine Based Companion Diagnostic Assay 18
Anetumab Ravtansine Based Companion Diagnostic Assay Product Overview 18
BET Inhibitor Based Companion Diagnostic Assay 19
BET Inhibitor Based Companion Diagnostic Assay Product Overview 19
C4.4a-ADC Based Companion Diagnostic Assay 20
C4.4a-ADC Based Companion Diagnostic Assay Product Overview 20
Ciprofloxacin Dry Powder Inhaler 21
Ciprofloxacin Dry Powder Inhaler Product Overview 21
Companion Diagnostic DNA Test 22
Companion Diagnostic DNA Test Product Overview 22
Cotavance Paclitaxel Coated Balloon Angioplasty Catheter 23
Cotavance Paclitaxel Coated Balloon Angioplasty Catheter Product Overview 23
FGFR2 - ADC Based Companion Diagnostic Assay 24
FGFR2 - ADC Based Companion Diagnostic Assay Product Overview 24
FGFR2 Inhibitor Based Companion Diagnostic Assay 25
FGFR2 Inhibitor Based Companion Diagnostic Assay Product Overview 25
LNG-IUS16 26
LNG-IUS16 Product Overview 26
MPS1 Inhibitor Based Companion Diagnostic Assay 27
MPS1 Inhibitor Based Companion Diagnostic Assay Product Overview 27
ODM-201 Based Companion Diagnostic Assay 28
ODM-201 Based Companion Diagnostic Assay Product Overview 28
PAN-FGFR Inhibitor Based Companion Diagnostic Assay 29
PAN-FGFR Inhibitor Based Companion Diagnostic Assay Product Overview 29
PI3K Inhibitor Based Companion Diagnostic Assay 30
PI3K Inhibitor Based Companion Diagnostic Assay Product Overview 30
Polyurethane Adhesive System 31
Polyurethane Adhesive System Product Overview 31
PSMA BiTE Antibody Based Companion Diagnostic Assay 32
PSMA BiTE Antibody Based Companion Diagnostic Assay Product Overview 32
PTEFB Inhibitor Based Companion Diagnostic Assay 33
PTEFB Inhibitor Based Companion Diagnostic Assay Product Overview 33
Radium-223 Dichloride Based Companion Diagnostic Assay 34
Radium-223 Dichloride Based Companion Diagnostic Assay Product Overview 34
Refametinib Based Companion Diagnostic Assay 35
Refametinib Based Companion Diagnostic Assay Product Overview 35
Regorafenib Based Companion Diagnostic Assay 36
Regorafenib Based Companion Diagnostic Assay Product Overview 36
Roniciclib Based Companion Diagnostic Assay 37
Roniciclib Based Companion Diagnostic Assay Product Overview 37
Silica Gel Wound Dressing 38
Silica Gel Wound Dressing Product Overview 38
Sorafenib Based Companion Diagnostic Assay 39
Sorafenib Based Companion Diagnostic Assay Product Overview 39
Bayer HealthCare AG - Key Competitors 40
Bayer HealthCare AG - Key Employees 41
Bayer HealthCare AG - Key Employee Biographies 43
Bayer HealthCare AG - Locations And Subsidiaries 44
Head Office 44
Other Locations and Subsidiaries 44
Recent Developments 45
Bayer HealthCare AG, Recent Developments 45
Nov 15, 2016: FDA approves Essure labeling with important safety information for patients and physicians 45
Oct 03, 2016: Lawsuits Against Bayer Over Essure Birth Control Device Injuries To Be Coordinated Before A Single Judge Following Argument by Grant and Eisenhofer 45
Feb 29, 2016: FDA Outlines Actions for Continued Safe, Effective and Appropriate Use of Essure for Permanent Birth Control 46
Feb 29, 2016: FDA takes additional action to better understand safety of Essure, inform patients of potential risks 46
Feb 03, 2016: Baron and Budd Investigating Potential Litigation Involving Essure Permanent Birth Control Device 47
Jan 20, 2016: Erin Copeland Co-Representing CA Essure Victims in Civil Lawsuit 48
Jan 14, 2016: Scrutiny of Essure Increases as Women Come Forward Claiming Permanent Injuries 48
Nov 24, 2015: FDA Anticipates Communicating Its Actions On Essure System In February 2016 49
Oct 13, 2015: Device Used for Permanent Female Birth Control Carries Heightened Risk for Post-Procedure Operation 49
Sep 25, 2015: Bayer Receives FDA Approval for BETACONNECT - First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis Treatment 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51


List of Tables
Bayer HealthCare AG Pipeline Products and Clinical Trials Overview 8
Bayer HealthCare AG Pipeline Products by Equipment Type 8
Bayer HealthCare AG Pipeline Products by Indication 9
Bayer HealthCare AG, Key Facts 10
Bayer HealthCare AG, Major Products and Services 11
Bayer HealthCare AG Number of Pipeline Products by Development Stage 13
Bayer HealthCare AG Pipeline Products Summary by Development Stage 14
AKT1/2 Inhibitor Based Companion Diagnostic Assay - Product Status 16
AKT1/2 Inhibitor Based Companion Diagnostic Assay - Product Description 16
Analgesic Coated Silica Gel Fiber - Product Status 17
Analgesic Coated Silica Gel Fiber - Product Description 17
Anetumab Ravtansine Based Companion Diagnostic Assay - Product Status 18
Anetumab Ravtansine Based Companion Diagnostic Assay - Product Description 18
BET Inhibitor Based Companion Diagnostic Assay - Product Status 19
BET Inhibitor Based Companion Diagnostic Assay - Product Description 19
C4.4a-ADC Based Companion Diagnostic Assay - Product Status 20
C4.4a-ADC Based Companion Diagnostic Assay - Product Description 20
Ciprofloxacin Dry Powder Inhaler - Product Status 21
Ciprofloxacin Dry Powder Inhaler - Product Description 21
Companion Diagnostic DNA Test - Product Status 22
Companion Diagnostic DNA Test - Product Description 22
Cotavance Paclitaxel Coated Balloon Angioplasty Catheter - Product Status 23
Cotavance Paclitaxel Coated Balloon Angioplasty Catheter - Product Description 23
FGFR2 - ADC Based Companion Diagnostic Assay - Product Status 24
FGFR2 - ADC Based Companion Diagnostic Assay - Product Description 24
FGFR2 Inhibitor Based Companion Diagnostic Assay - Product Status 25
FGFR2 Inhibitor Based Companion Diagnostic Assay - Product Description 25
LNG-IUS16 - Product Status 26
LNG-IUS16 - Product Description 26
MPS1 Inhibitor Based Companion Diagnostic Assay - Product Status 27
MPS1 Inhibitor Based Companion Diagnostic Assay - Product Description 27
ODM-201 Based Companion Diagnostic Assay - Product Status 28
ODM-201 Based Companion Diagnostic Assay - Product Description 28
PAN-FGFR Inhibitor Based Companion Diagnostic Assay - Product Status 29
PAN-FGFR Inhibitor Based Companion Diagnostic Assay - Product Description 29
PI3K Inhibitor Based Companion Diagnostic Assay - Product Status 30
PI3K Inhibitor Based Companion Diagnostic Assay - Product Description 30
Polyurethane Adhesive System - Product Status 31
Polyurethane Adhesive System - Product Description 31
PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Status 32
PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Description 32
PTEFB Inhibitor Based Companion Diagnostic Assay - Product Status 33
PTEFB Inhibitor Based Companion Diagnostic Assay - Product Description 33
Radium-223 Dichloride Based Companion Diagnostic Assay - Product Status 34
Radium-223 Dichloride Based Companion Diagnostic Assay - Product Description 34
Refametinib Based Companion Diagnostic Assay - Product Status 35
Refametinib Based Companion Diagnostic Assay - Product Description 35
Regorafenib Based Companion Diagnostic Assay - Product Status 36
Regorafenib Based Companion Diagnostic Assay - Product Description 36
Roniciclib Based Companion Diagnostic Assay - Product Status 37
Roniciclib Based Companion Diagnostic Assay - Product Description 37
Silica Gel Wound Dressing - Product Status 38
Silica Gel Wound Dressing - Product Description 38
Sorafenib Based Companion Diagnostic Assay - Product Status 39
Sorafenib Based Companion Diagnostic Assay - Product Description 39
Bayer HealthCare AG, Key Employees 41
Bayer HealthCare AG, Key Employee Biographies 43
Bayer HealthCare AG, Subsidiaries 44

List of Figures
Bayer HealthCare AG Pipeline Products by Equipment Type 9
Bayer HealthCare AG Pipeline Products by Development Stage 13

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Intercellular Adhesion Molecule 1 (Major Group Rhinovirus ...

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2016

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease ...

Hand, Foot and Mouth Disease - Pipeline Review, H2 2016

Hand, Foot and Mouth Disease - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Hand, Foot and Mouth Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hand, Foot and Mouth Disease - Pipeline Review, H2 ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.